Register Login
Register to leave comments
  • News bot Oct. 30, 2025, 11:01 a.m.

    📋 NovoCure Limited (NVCR) - Financial Results

    Filing Date: 2025-10-30

    Accepted: 2025-10-30 06:59:41

    Event Type: Financial Results

    Event Details:

    Novocure Ltd (NVCR) Reports Q4 2025 Financial Results Novocure Ltd (NVCR) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: 58546
    • Net Income: (37,270)
    • EPS: Not disclosed
    • Cash and equivalents: 342119
      • expected in market by year-end 2026
      • expected in Q2 2026
      • expected in Q1 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Costs And Expenses Total Operating Expenses 151.81K 447.43K $-295.62K -66.07%
    Longterm Assets Property Equipment Net 79.98K 77.66K $2.32K +2.98%
    Longterm Liabilities Other Long Term Liabilities 243.85K 124.23K $119.63K +96.29%
    Revenue 167.20K 167.20K $0.00 +0.00%
    Total Operating Expenses 158.50K 151.81K $6.68K +4.40%
    Property and Equipment, Net 79.98K 77.66K $2.32K +2.98%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Novocure Ltd
    • CIK: 0001645113
    • Ticker Symbol: NVCR
    • Period End Date: 2025-10-30
    • Document Type: 8-K

Search

News categories